Answers are grounded in this paper and cite their sources.
Advanced lipid nanomaterials demonstrate spleen-targeting mRNA delivery, suggesting enhanced immune responses.
Advanced functional lipid nanomaterials with precise structure-function relationships are pivotal to overcome extrahepatic delivery barriers in mRNA therapy. Here, we develop a chloroquine-inspired spleen-targeting system (CISTS) through rational molecular hybridization and combinatorial screening of quinoline-derived lipids. Computational simulations revealed enhanced mRNA binding via hydrogen bonding networks and TLR4/TLR7-targeting capacity inherent to chloroquine-mimetic headgroups. This molecular design enables CISTS to exhibit unique self-assembly behavior, as validated by cryo-EM and molecular dynamics, which promotes high-efficiency mRNA encapsulation and endosomal escape. Upon intravenous administration, CISTS achieves spleen-biased mRNA transfection while concurrently activating TLR-mediated immune pathways, conferring self-adjuvanting activity that drives potent Th1-biased responses. In murine melanoma models, CISTS-delivered ovalbumin mRNA elicited robust antigen-specific immunity, significantly suppressing tumor growth and extending survival. This work establishes a new paradigm of hybrid lipid nanomaterials that intrinsically integrates targeted delivery and immunostimulation, advancing next-generation mRNA vaccine design.
No takes yet. Share an insight, caveat, or question.
LI et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: